# Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis

> **NCT05119452** · NA · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 85 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)

## Key facts

- **NCT ID:** NCT05119452
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2024-09
- **Final completion:** 2024-09
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2021-11-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05119452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05119452, "Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05119452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*